Randhawa Simrat bought DNTH
September 1, 2026 · Form 4 insider transaction
Randhawa Simrat bought 7,500 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $134.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$17.88
Total value
$134.1K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after11,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.